Holen Sie sich die Stockscreener-App
55.26
5.34%
2.7784
Schlusskurs vom Vortag:
$52.48
Offen:
$51.74
24-Stunden-Volumen:
648.24K
Relative Volume:
1.47
Marktkapitalisierung:
$2.62B
Einnahmen:
$1.10B
Nettoeinkommen (Verlust:
$186.50M
KGV:
14.61
EPS:
3.7817
Netto-Cashflow:
$267.19M
1W Leistung:
-5.52%
1M Leistung:
-17.73%
6M Leistung:
-12.52%
1J Leistung:
-33.28%
1-Tages-Spanne:
$51.24
$55.31
1-Wochen-Bereich:
$51.24
$60.35
52-Wochen-Spanne:
$51.24
$89.37
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
55.27 | 2.48B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
18.20 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.24 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.68 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.02 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Prestige Consumer Healthcare (PBH) Is Down 10.3% After Rising FTC Scrutiny and Bearish SignalsWhat's Changed - Yahoo Finance
PBH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Prestige Consumer Healthcare Inc (PBH) Trading Down 6.76% on Apr 2 - gurufocus.com
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo Finance
PBH Plummets 8.6% Intraday: Is This A Deep Correction Or A Buying Opportunity? - Bitget
Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month LowHere's Why - MarketBeat
Prestige Consumer Healthcare stock hits 52-week low at 56.86 USD - Investing.com India
PBH Technical Analysis & Stock Price Forecast - Intellectia AI
Allspring Global Investments Holdings LLC Acquires 21,085 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Technical Signals Behind (PBH) That Institutions Follow - news.stocktradersdaily.com
Prestige bets $1 billion on world's most iconic nasal strip - MSN
Prestige Consumer Health to acquire Breathe Right for $1.045B - MSN
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard (PBH) amendment shows 0 shares; reporting split after Jan 12, 2026 - Stock Titan
Swing Trade: Can Prestige Consumer Healthcare Inc sustain earnings growthShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Market Catalysts: Can Prestige Consumer Healthcare Inc continue delivering strong returns2026 Major Catalysts & Daily Oversold Bounce Ideas - baoquankhu1.vn
Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5% - Insider Monkey
Congress Asset Management Co. Has $20.91 Million Stock Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Nordea Investment Management AB Has $37.81 Million Holdings in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. $PBH Shares Bought by JPMorgan Chase & Co. - marketbeat.com
User - The Chronicle-Journal
Foundation Consumer Healthcare sells portion of consumer health business - Drug Store News
Aug Big Picture: What are analysts price targets for Prestige Consumer Healthcare Inc2026 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Prestige Consumer to buy Breathe Right brand in $1.05 billion deal - msn.com
Prestige Consumer Healthcare Inc. (PBH) Breathe RightM&A CallSlideshow (NYSE:PBH) 2026-03-21 - Seeking Alpha
Published on: 2026-03-21 21:46:33 - baoquankhu1.vn
Prestige Consumer Healthcare to acquire Breathe Right for $1.05bn By Investing.com - Investing.com Australia
Health Care Down Amid Regulatory Fears -- Health Care Roundup - MarketScreener
PBH: $1.045B acquisition of Breathe Right boosts revenue, margins, and global scale with low integration risk - TradingView
Prestige Consumer Healthcare: Adding A Prestigious Brand (NYSE:PBH) - Seeking Alpha
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare to Buy Breathe Right, Other Brands for $1.045 Billion - WSJ
Prestige Consumer Healthcare Acquires Breathe Right for $1.045 Billion, Expanding Global OTC Portfolio and Enhancing Financial Profile 13 - Minichart
Prestige Picks Up Breathe Right In $1.05B Deal - Law360
Prestige Consumer Healthcare (NYSE:PBH) Shares Gap UpTime to Buy? - MarketBeat
Prestige Consumer Healthcare to Acquire Consumer Health, Wellness Brands Portfolio in $1.05 Billion Deal - marketscreener.com
Prestige Consumer Healthcare To Acquire Breathe Right - citybiz
Prestige Consumer Healthcare to acquire Breathe Right for $1.05bn - Investing.com
Prestige Buys Breathe Right: $1.045B Deal to Add Nasal Strip LeaderNews and Statistics - IndexBox
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip - Benzinga
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip - Benzinga
Prestige Consumer Healthcare (PBH) to Acquire Breathe Right for $1.045 Billion - gurufocus.com
Prestige Consumer Healthcare to acquire Breathe Right for $1.045 billion By Investing.com - Investing.com Canada
Prestige Consumer Healthcare : Acquisition of Breathe Right® Conference Call Presentation - marketscreener.com
Prestige Consumer to Acquire Breathe Right Brand Portfolio - TipRanks
Prestige Consumer Healthcare to Buy Breathe Right Brand for Over $1 Billion - marketscreener.com
Foundation Consumer Healthcare Sells Portion of Consumer Health Business - The Manila Times
Prestige Consumer Healthcare to Acquire Breathe Right and Other OTC Brands for $1.045 Billion - TradingView
Prestige Consumer Healthcare Inc. Announces Agreement to Acquire Breathe Right Brand Portfolio for $1.045 Billion - Quiver Quantitative
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):